Natural compounds from plants and animals have long been used in drug development, but mushrooms remain underexplored despite their rich chemical potential. Now, researchers from Japan have ...
This Biotech Stock is Defying the Odds—Find Out Why ImmunoPrecise Antibodies (IPA) is Trending Today
ImmunoPrecise has outperformed the broader market in a spectacular fashion. As of now, IPA’s YTD performance stands at +81.64%, a staggering increase compared to the S&P 500’s YTD performance of just ...
Pharmaceutical firms that specialize in utilizing AI to speed up the drug discovery process are soaring today.
Casdozokitug, in combination with atezolizumab/bevacizumab, final data demonstrate durability of response and improvement in depth of response ...
Recent results raise hope of new "broad, pan-tumor platform" like Keytruda. The emerging drugs are bispecific antibodies that ...
We recently compiled a list of the 10 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a ...
AUSTIN - ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA), a micro-cap biotech company with a market capitalization of $18.78 ...
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) today announced the launch of its AI-powered pipeline of both optimized and new therapeutics, a system set to transform therapeutic development. By ...
General Manager and CEO of Junshi Biosciences, Dr. Jianjun ZOU, said, “Toripalimab has made significant strides in its internationalization. As of today, toripalimab has been approved in 35 countries ...
With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback